Skip to content
healthcare.dev

ADCETRIS

NDC 51144-050, brentuximab vedotin, injection, powder, lyophilized, for solution, from SEAGEN INC..

Product NDC
51144-050
Status
Listed
Labeler
SEAGEN INC.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125388
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51144-050 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BRENTUXIMAB VEDOTIN50 mg/10.5mL

Pharmacologic classes

CD30-directed Antibody Interactions [MoA]; CD30-directed Immunoconjugate [EPC]; Immunoconjugates [CS]; Microtubule Inhibition [PE]

Package NDCNDC-11Package
51144-050-01511440050011 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01) / 10.5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3904f8dd-1aef-3490-e48f-bd55f32ed67f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=51144-050

Use it

Look up 51144-050 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51144-050 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51144-050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.